CG&D
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation

Right arrow Help viewing high resolution images
Right arrow Return to article


Fig. 5. IFN-{alpha} effects on c-myc and Cdc25A expression. Analysis of c-myc and Cdc25A regulation in quiescent (Day 0), PHA-treated (Day 3), IL-2-treated (Days 4–6), and IL-2/IFN-{alpha}-treated (Days 4–6) cells by immunoblotting (A), Northern blot analysis (B), and immunoblotting (C). Tubulin (A and C) and 18S and 28S rRNA (B) served as controls for equal loading.





Right arrow Return to article


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation